David LaPointe

David Lapointe is a biotech executive and entrepreneur with experience building and advancing life-sciences companies across oncology, immunology, and diagnostics. He leads HDT Bio’s business-development and oncology strategy activities, including strategic partnerships, clinical-development collaborations, and venture-building initiatives.

Based in Montreal, David is building HDT Bio Canada’s clinical and operating capabilities while working with investigators, clinical sites, strategic partners, and investors to advance HDT’s oncology portfolio. His work focuses on translating differentiated immune-platform technologies into focused clinical programs and durable new ventures designed to create meaningful patient and commercial value.